Reported Events

The following are adverse event alerts ASRS has sent to its members.  To ensure you receive these important updates, please verify the email address associated with your member profile.

ASRS Tracking Spike in Reports of Cornea Complications Possibly Linked to Lubricant Use During Vitrectomy September 26, 2016

FDA Changes Botox Safety Labeling  September 10, 2015

FDA Expands Warning on Compounded or Repackaged Drugs Stored in Becton-Dickinson (BD) Syringes 

Rare, Serious Condition Can Affect Patients Following Uncomplicated Cataract Surgery—Exploring Possible Link to Vancomycin August 27, 2015

FDA: Allergan Recalls Refresh Lacri-Lube, Refresh PM, FML 0.1% and Blephamide 10%/0.2% August 25, 2015

FDA: Picato (ingenol mebutate) Gel Can Cause Severe Eye Injuries August 21, 2015

FDA: Do Not Use Compounded Drugs Stored in Becton-Dickinson (BD) 3-ml and 5-ml Syringes August 19, 2015

FDA Changes Eylea Safety Labeling August 14, 2015

FDA Changes Avastin Safety Labeling June 12, 2015

FDA: Hospira, Inc Recalls Bupivacaine HCl Injection April 24, 2015

LifeCare Flexible Intravenous Solutions by Hospira, Inc. Recalls Lots Containing Sodium Chloride and Dextrose Injection Solutions October 15, 2014
FDA Alert: Oregon Compounding Centers, Inc (Creative Compounds) Recalls Avastin - October 10, 2014
FDA Alert: Hospira Recalls Vancomycin Hydrochloride October 8, 2014
 
FDA Alert: Pharmacy Creations Recalls Tropi/Cyclo/Phenyl/Tobra/Flurb September 7, 2014
 
FDA Alert: Martin Avenue Pharmacy Recalls Compounded Sterile Preparations September 2, 2014
FDA Alert: Customed Recalls Sterile Convenience Surgical Packs - August 26, 2014
FDA: Hospira Recalls Lidocaine HCI Injection, USP, 2% - July 30, 2014
FDA Alert: FDA Issues Safety Labeling Change for Jetrea - July 15, 2014
FDA: Hospira Recalls Marcaine (Bupivacaine HCI Injection, USP) - June 18, 2014
FDA: Hospira Recalls Dobutamine Injection (250mg/20mL) - May 15, 2014
FDA: Hospira Recalls 0.25% Marcaine (Bupivacaine HCl Injection, USP) - April 22, 2014
FDA: Hospira Recalls 1% Lidocaine HCl Preservative-Free Injection - April 19, 2014

FDA Approves Ozurdex Safety Labeling Changes - March 19, 2014

FDA Issues Safety Labeling Changes for Systemic Avastin - January 10, 2014

FDA: Baxter Recalls 5% Dextrose Injection, USP and 0.9% Sodium Chloride Injection, USP Intravenous Solutions - December 27, 2013

FDA: Hospira Recalls Lidocaine HCl Injection 2%, 5 mL Vial - December 24, 2013

FDA: Abrams Royal Pharmacy Recalls Sterile Compounded Products - December 19, 2013

FDA: Nature's Pharmacy & Compounding Center of North Carolina Recalls Sterile Compounded Products - November 18, 2013

FDA: Michigan's Specialty Medicine Compounding Pharmacy Recalls Bevacizumab - October 21, 2013

FDA: Hospira Recalls 1% Lidocaine HCL Injection - October 5, 2013

ASRS TSC Update: Aflibercept-Related Sterile Inflammation - September 19, 2013

FDA: Hospira Recalls Bupivacaine HCL Injection Single-Dose Vials - September 14, 2013

FDA: Avella Specialty Pharmacy Recalls Avastin - September 9, 2013

FDA: Alaire Pharmaceuticals Recalls OTC Carboxymethylcellulose Sodium 0.5% Solution - September 9, 2013

FDA Warns Fluoroquinolones Pose Risk of Possibly Permanent Nerve Damage- August 15, 2013

FDA Changes Bactrim Safety Labeling - August 13, 2013

FDA: Specialty Compounding in Cedar Park, Texas Recalls Sterile Products - August 11, 2013

Michigan's Beacon Hill Medical Pharmacy/Rxtra Solutions Recalls Sterile Injectables - August 1, 2013

FDA Changes Eylea Safety Labeling - July 12, 2013

FDA Update: Adverse Reactions Reported to Steroid Injections from Tennessee's Main Street Family Pharmacy - June 7, 2013

Tennessee's Main Street Family Pharmacy Recalls All Sterile Products - May 28, 2013

Tennessee's Main Street Family Pharmacy Reports Adverse Reactions to Steroid Injections - May 24, 2013

FDA: NuVision Pharmacy in Dallas Lacks Sterility Assurance - May 18, 2013

FDA: The Compounding Shop Lacks Sterility Assurance – May 8, 2013

FDA: Potiga (Ezogabine) Linked to Retinal Abnormalities – April 27, 2013

Clinical Specialties Issues Voluntary Nationwide Recall of Avastin – March 18, 2013

Endophthalmitis Cases Reported – March 15, 2013

FDA: Gilead Recalls Vistide (Cidofovir Injection) – February 19, 2013

FDA: Bausch+Lomb Recalls 27G Cannula Packed in Amvisc – January 23, 2013

FDA Issues Safety Labeling Changes for Ozurdex – October 18, 2012